AU3538689A - Peptides inhibitors of hiv induced cell fusions and syncytia formation - Google Patents

Peptides inhibitors of hiv induced cell fusions and syncytia formation

Info

Publication number
AU3538689A
AU3538689A AU35386/89A AU3538689A AU3538689A AU 3538689 A AU3538689 A AU 3538689A AU 35386/89 A AU35386/89 A AU 35386/89A AU 3538689 A AU3538689 A AU 3538689A AU 3538689 A AU3538689 A AU 3538689A
Authority
AU
Australia
Prior art keywords
avg
peptide according
peptide
alkylating agent
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35386/89A
Other languages
English (en)
Inventor
Richard W. Compans
Randy Owens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alabama at Birmingham UAB
Original Assignee
University of Alabama UA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alabama UA filed Critical University of Alabama UA
Publication of AU3538689A publication Critical patent/AU3538689A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU35386/89A 1988-04-07 1989-04-06 Peptides inhibitors of hiv induced cell fusions and syncytia formation Abandoned AU3538689A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US17867288A 1988-04-07 1988-04-07
US32827389A 1989-03-24 1989-03-24
US328273 1989-03-24
US178672 2002-06-24

Publications (1)

Publication Number Publication Date
AU3538689A true AU3538689A (en) 1989-11-03

Family

ID=26874539

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35386/89A Abandoned AU3538689A (en) 1988-04-07 1989-04-06 Peptides inhibitors of hiv induced cell fusions and syncytia formation

Country Status (6)

Country Link
EP (1) EP0408663A4 (de)
JP (1) JPH03504722A (de)
AU (1) AU3538689A (de)
DK (1) DK241490A (de)
PT (1) PT90229A (de)
WO (1) WO1989009785A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
ES2325644B1 (es) 2005-12-30 2010-06-28 Universidad Del Pais Vasco (Upv/Ehu) Hexapeptidos no proteolizables inhibidores de la glicoproteina 41 del virus del sida.
JP5664992B2 (ja) * 2009-08-26 2015-02-04 国立大学法人名古屋大学 細胞特異的ペプチド及びその用途
EP3518968B1 (de) 2016-10-03 2022-01-05 The U.S.A. as represented by the Secretary, Department of Health and Human Services Hiv-1-env-fusionspeptid-immunogene und deren verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792032A (en) * 1970-07-31 1974-02-12 Farmaceutical Soc Polypeptides related to the c-terminal heptapeptide of bombesin and alytesin
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection

Also Published As

Publication number Publication date
PT90229A (pt) 1989-11-10
JPH03504722A (ja) 1991-10-17
WO1989009785A1 (en) 1989-10-19
EP0408663A1 (de) 1991-01-23
DK241490A (da) 1990-12-06
DK241490D0 (da) 1990-10-05
EP0408663A4 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
Dorfman et al. Functional domains of the capsid protein of human immunodeficiency virus type 1
Bosch et al. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site
Fitzon et al. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication
Gürtler et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon
Mammano et al. Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis
Cheng-Mayer et al. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120
Page et al. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity
US5464933A (en) Synthetic peptide inhibitors of HIV transmission
Guy et al. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein
US5221610A (en) Diagnostic method and composition for early detection of HIV infection
Flexner et al. Characterization of human immunodeficiency virus gag/pol gene products expressed by recombinant vaccinia viruses
US5849304A (en) Recombinant vaccinia virus expressing human retrovirus gene
US5342922A (en) Inhibitors of retroviral protease
US6468539B1 (en) Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
Horwitz et al. Novel human endogenous sequences related to human immunodeficiency virus type 1
OWENS et al. Oligopeptide inhibitors of HIV-induced syncytium formation
Chakrabarti et al. Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus
EP0853662A1 (de) Neuer replikationsfähiger menschlicher immunschwäche virus typ ii (hiv-2) proviraler klon hiv-2kr
WO1994015634A9 (en) Tat and rev oligopeptides in hiv treatment
Hunter gp41, a multifunctional protein involved in HIV entry and pathogenesis
Wu et al. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles
Slepushkin et al. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein
AU3538689A (en) Peptides inhibitors of hiv induced cell fusions and syncytia formation
Berger et al. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release
DeVICO et al. Purification and partial characterization of human immunodeficiency virus type 2 reverse transcriptase